Search

everythinglearnresearchcommunity

for

Search:↓

The PROCLIPI study found markers that help predict outcomes in skin lymphoma patients.

The LTF gene may help predict and manage nonspecific orbital inflammation.

Hair loss is common in lupus patients and can be permanent or reversible, depending on the type, with various treatments available.

Low free thyroxine (FT4) is common in young lupus patients and needs quick diagnosis and treatment.

Higher EULAR/ACR scores in SLE patients predict more organ damage.

Hair loss in systemic lupus erythematosus patients is unique and improves with treatment.

Memory T cells in the skin balance staying put and moving into the blood, clustering around hair follicles, and increasing in number after infection.

Unique fat cells near fibrotic areas contribute to systemic sclerosis progression.

Tranilast successfully treated a man's skin sarcoidosis when other treatments failed.

A woman with skin and joint issues progressed from one type of lupus to another, highlighting the need to recognize complex conditions.

The skin is a large organ that plays a role in the immune system.

Understanding how Regulatory T Cells work could help create treatments for certain skin diseases and cancers.

A kidney transplant patient developed leprosy, likely due to immunosuppression and genetic factors, and improved with treatment.

Systemic lupus erythematosus treatment can restore vision in patients with retinal artery occlusion.

Mesenchymal stem cells and their secretome may offer a safe and effective treatment for systemic lupus erythematosus.

The nodule was a benign cutaneous lymphadenoma, not cancer, and was successfully removed.

A 68-year-old woman with lupus and blood disorders improved after increased steroids and immunoglobulin treatment.

The woman has Discoid Lupus Erythematosus and needs specialist care.

JSLE patients often have more hormone and metabolism issues, so regular check-ups and preventing obesity can help.

Balancing treatment effectiveness with side effects is crucial for relapsed follicular non-Hodgkin's lymphoma, especially in older patients.

Vesiculobullous lesions should be considered part of canine cutaneous epitheliotropic T-cell lymphoma.

This method effectively reconstructs scarred penopubic junctions after surgery.

Memory regulatory T cells need IL-7, not IL-2, to stay in peripheral tissues.

A woman with lupus and Kikuchi-Fujimoto disease improved with treatment.

Protein-losing enteropathy worsened with lupus symptoms but improved with prednisolone.

Trichoscopy can help identify systemic diseases, not just hair and scalp issues.

Type 3 Innate Lymphoid Cells help maintain skin health and balance, and are involved in skin diseases and healing.

SLE should be considered in unexplained fevers, even in males.

Most children with childhood-onset lupus in Baghdad responded well to treatment, but some developed chronic kidney disease or died.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.